Consequences of IFIT Gene Evolution on Species-Specific Antiviral Immunity
IFIT 基因进化对物种特异性抗病毒免疫的影响
基本信息
- 批准号:9272360
- 负责人:
- 金额:$ 10.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-12 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAntiviral AgentsBindingBiochemistryBiological AssayCell LineComplementDataDevelopmentEvolutionFamilyFoundationsFundingFutureGene FamilyGene TargetingGenesGeneticGenetic TranslationGenetic VariationGoalsHIVHumanImmune systemImmunityIn VitroIndividualInfluenzaInnate Immune SystemIntegration Host FactorsInterferonsLeadLightMammalsMessenger RNAMethylationModelingMolecularMusNamesNatural ImmunityNucleotidesPhylogenetic AnalysisPredispositionPrimatesPropertyProteinsRaceRecording of previous eventsResearchResearch Project GrantsResistanceSevere Acute Respiratory SyndromeSmallpoxSpecificityStructureSystemTestingTherapeuticTranslationsVaccinia virusVesicular stomatitis Indiana virusViralVirusVirus DiseasesVirus ReplicationYeastsZoonosesantiviral immunityarmgenetic signatureinsightinterdisciplinary approachmRNA cappingmammalian genomemembermolecular recognitionmutantnovelpandemic diseaseparalogous genepreventprogramspublic health relevanceresponsesuccesstransmission processviral transmissionvirologyyeast genetics
项目摘要
DESCRIPTION (provided by applicant): Some of the most deadly human viral infections are the result of zoonoses from other species. This makes identification of host factors that define human susceptibility to viruses currently circulating in other species an essential part of efforts
to prevent and cure zoonotic infections. Host factors known to restrict cross-species transmission are some of the most rapidly evolving factors in mammalian genomes, often as a result of evolutionary 'arms races' with viruses. My research focuses uses these evolutionary signatures of gene adaptation to discover and characterize new mechanisms of innate immunity and determine how genetic variation in host immunity impacts viral transmission. My proposal focuses on the IFIT (Interferon-induced with tetratricopeptide repeat) gene family, some of the most highly upregulated genes in response to viral infection. I have found that IFITs are also among the most rapidly evolving genes in mammals, leading me to hypothesize that inter-species difference in IFIT gene repertoire and sequence will influence the success of viral transmission between species. My lab will test these hypotheses using a multidisciplinary approach that integrates insights from biochemistry, evolutionary genetics, and virology. In Aim 1, we will examine how IFIT1 evolution, both in sequence and due to gene gain and loss, influences the viruses that different hosts can restrict. In Aim 2, I will determine how a human IFIT1 functions to restrict viral replication. These studies will not only shed light on the mechanistic consequences of IFIT evolution, but will also identify species-specific changes in innate antiviral immunity. Finally, more broadly, my research will highlight the power of using an evolution-guided approach to discover and characterize factors important for cross-species viral transmission.
描述(由申请人提供):一些最致命的人类病毒感染是其他物种的人畜共患病的结果。这使得确定确定人类对目前在其他物种中传播的病毒的易感性的宿主因素成为努力的重要组成部分
预防和治疗人畜共患传染病。已知限制跨物种传播的宿主因素是哺乳动物基因组中进化最快的一些因素,通常是与病毒进化“军备竞赛”的结果。我的研究重点是使用这些基因适应的进化特征来发现和表征先天免疫的新机制,并确定宿主免疫中的遗传变异如何影响病毒传播。我的建议集中在IFIT(干扰素诱导与tetratricopeptide repeat)基因家族,一些最高度上调的基因在病毒感染的反应。我发现IFIT也是哺乳动物中进化最快的基因之一,这使我假设IFIT基因库和序列的种间差异将影响种间病毒传播的成功。我的实验室将使用多学科方法来测试这些假设,该方法整合了生物化学,进化遗传学和病毒学的见解。在目标1中,我们将研究IFIT1的进化,无论是在序列上还是由于基因的获得和丢失,如何影响不同宿主可以限制的病毒。在目标2中,我将确定人类IFIT1如何发挥作用以限制病毒复制。这些研究不仅将阐明IFIT进化的机制后果,而且还将确定先天抗病毒免疫的物种特异性变化。最后,更广泛地说,我的研究将突出使用进化引导的方法来发现和表征跨物种病毒传播的重要因素的力量。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew Daugherty其他文献
Matthew Daugherty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew Daugherty', 18)}}的其他基金
Pathogen-driven evolution of innate antiviral defense mechanisms
先天抗病毒防御机制的病原体驱动进化
- 批准号:
10188563 - 财政年份:2019
- 资助金额:
$ 10.8万 - 项目类别:
Pathogen-driven evolution of innate antiviral defense mechanisms
先天抗病毒防御机制的病原体驱动进化
- 批准号:
10424420 - 财政年份:2019
- 资助金额:
$ 10.8万 - 项目类别:
Pathogen-driven evolution of innate antiviral defense mechanisms
先天抗病毒防御机制的病原体驱动进化
- 批准号:
10646458 - 财政年份:2019
- 资助金额:
$ 10.8万 - 项目类别:
Pathogen-driven evolution of innate antiviral defense mechanisms
先天抗病毒防御机制的病原体驱动进化
- 批准号:
9982346 - 财政年份:2019
- 资助金额:
$ 10.8万 - 项目类别:
Consequences of IFIT Gene Evolution on Species-Specific Antiviral Immunity
IFIT 基因进化对物种特异性抗病毒免疫的影响
- 批准号:
8951615 - 财政年份:2016
- 资助金额:
$ 10.8万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 10.8万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 10.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 10.8万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 10.8万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 10.8万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 10.8万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 10.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 10.8万 - 项目类别: